Print friendly version
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
A recent review estimated the 5-year survival rate for people with ameloblastic carcinoma to be around 73%. Ameloblastic carcinoma does have the potential to spread (metastasize) to distant parts of the body, such as the lung or brain. Metastasis adversely affects prognosis. The estimated 5-year survival rate for people with metastatic disease is around 21%.
Last updated: 10/19/2011
- Yoon HJ, Hong SP, Lee JI, Lee SS, Hong SD. Ameloblastic carcinoma: an analysis of 6 cases with review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Dec;108(6):904-13; http://www.ncbi.nlm.nih.gov/pubmed/19800270. Accessed 10/18/2011.